Changes of body composition after valve surgery in patients with mitral valve disease by 심지영 et al.
RESEARCH ARTICLE
Changes of body composition after valve
surgery in patients with mitral valve disease
Sung-Ai Kim1, Min-Kyung Kang1, Chi Young Shim2, Sak Lee3, Byung-Chul Chang3, Jong-
Won HaID2*
1 Division of Cardiology, Hallym Sacred Heart Hospital, Hallym University College of Medicine, Anyang,
Korea, 2 Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine,
Seoul, Korea, 3 Division of Cardiovascular Surgery, Severance Cardiovascular Hospital, Department of




Patients with chronic heart failure have alteration in body composition as a reduction in fat
mass, lean body mass and bone mass. However, body wasting in valvular heart disease
and the impact of corrective valvular surgery on body composition has not been
investigated.
Objectives
We hypothesized that body wasting in severe mitral valve (MV) diseases is reversible
through MV surgery.
Methods
Forty eight patients who were scheduled to undergo MV surgery were consecutively
enrolled after excluding patients with combined valvular heart disease, ischemic heart dis-
ease, cardiomyopathies, and diseases or who were taking medications that could affect
metabolism. All patients were subjected to simplified nutritional assessment questionnaire
(SNAQ) for appetite, laboratory tests, echocardiography, and dual-energy X-ray absorpti-
ometry (DXA) before and one year after MV surgery.
Results
One year after MV surgery, the patients showed increased appetite and improved laboratory
data as well as hemodynamic improvement.When we classified the patients according to
the primary MV lesion, no changes in body weight were observed in both patients with mitral
regurgitation (MR) and mitral stenosis (MS). However, significant increase in bone mineral
density and body fat percentage were observed in patients with MR and not in patients with
MS. In patients with MR, patients with Δfat 2% showed significantly higher pre-operative
estimated right ventricular systolic pressure (eRVSP) level and greater decrease in eRVSP
after surgery than those with Δfat < 2% and both ΔSNAQ and Δfat showed significant nega-
tive relationship with ΔeRVSP, respectively.
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Conclusions
In patients with severe MV disease, corrective MV surgery led to favorable outcomes in
wasting process as well as hemodynamic improvement. Particularly, right ventricular pres-
sure overload showed a close association with the changes in appetite and body fat percent-
age in patients with MR.
Introduction
Wasting process in heart failure (HF) has been known as an independent risk factor for mor-
tality [1]. Although the mechanism of apparent body wasting in HF is not yet clarified,
increased catabolism and decreased anabolism by dietary deficiency, malabsorption, and met-
abolic dysfunction have been proposed to be responsible for the development of cardiac
cachexia [2–3]. Consequently, body composition of cachectic patients has a reduction in fat
mass, lean body mass and bone mass [4–5], and the wasting process has significant influence
on the quality of life as they experience easy fatigue and muscle weakness as well as poor
prognosis.
Especially, body wasting in valvular heart diseases has received little attention. A previous
report has shown that all patients with severe mitral valve (MV) disease who underwent MV
surgery (replacement/annuloplasty) had experienced a marked increase in appetite, postopera-
tively [6]. However, the effect of corrective valve surgery on nutritional status and body com-
position is not clearly understood.
In this study, we enrolled patients with severe MV disease who underwent MV surgery, and
analyzed their body composition by dual-energy X-ray absorptiometry (DXA) and appetite
using questionnaire, as well as anthropometric and laboratory parameters, before and one year
after MV surgery. We hypothesized that the wasting process in patients with severe MV disease
is reversible through corrective MV surgery.
Materials and methods
1. Study population
We prospectively enrolled 48 patients with severe mitral valvular disease scheduled for MV
surgery (repair or replacement). Patients with combined significant valvular heart disease,
ischemic heart disease, cardiomyopathies, right ventricular (RV) dysfunction, previous MV
surgery, diabetes, cirrhosis or active hepatitis, thyroid disease, chronic inflammatory or infec-
tious diseases, and active malignancy (i.e. diseases that could affect metabolism, nutritional sta-
tus and body composition), known pregnancy, use of steroid, antidepressant, and other
appetite stimulants were excluded.
This study was approved by the Ethics Committee and Institutional Review Board of Yonsei
University College of Medicine, and written informed consent was obtained from all patients
prior to enrolment.
2. Short nutrition assessment questionnaire (SNAQ)
Appetite was measured using the Simplified Nutritional Appetite Questionnaire (SNAQ) [7].
The SNAQ includes four questions based on following numerical scale: A = 1, B = 2, C = 3,
D = 4, E = 5.
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1. My appetite is (A. very poor/ B. poor/ C. average/ D. good/ E. very good)
2. When I eat (A. I feel full after eating only a few mouthfuls/ B. I feel full after eating about a
third of a meal/ C. I feel full after eating over half of meal/ D. I feel full after eating most of
the meal/ E. I hardly ever feel full)
3. Food tastes (A. Very bad/ B. Bad/ C. Average/ D. Good/ E. very good)
4. Normally I eat (A. Less than one meal a day/ B. One meal a day/ C.Two meals a day/ D.
Three meals a day/ E. More than 3 meals a day).
The total SNAQ score range from four to 20. Those with SNAQ scores<14 has been
reported to be at significant risk for weight loss >5% within 6 months, with a sensitivity of
81.3%, and a specificity of 76.4% [7].
3. Echocardiography
Echocardiography was performed using a GE Vingmed System 7 ultrasound system (Horten,
Norway) with a 2.5-MHz transducer for image acquisition. Standard two-dimensional mea-
surements were obtained with the patient in the left lateral position. Left ventricular ejection
fraction (LVEF) was measured using the modified Simpson method. Left ventricular (LV) out-
flow tract diameter (LVOTd) was measured in the parasternal long axis view in early systole
immediately adjacent to the point of aortic cusp insertion. LVOT velocity–time integral (VTIL-
VOT) measured using pulsed wave Doppler was recorded from the apical five chamber view in
the LVOT, by placing the sample volume approximately five mm apically from the aortic valve
and aligning it parallel with blood flow. LV stroke volume (SV) was obtained by multiplying
the LVOT area by VTILVOT using the formula SV (ml) = LVOT area (cm
2) x VTILVOT (cm).
Left atrial (LA) volumes were calculated by biplane Simpson method using apical four and two
chamber views. The LA volume index (LAVI) was calculated as LA volume/body surface area
(mL/m2). Right ventricular systolic pressure (RVSP) was estimated from the maximal tricuspid
regurgitant jet velocity by using the modified Bernoulli equation (4V2) and the addition of esti-
mated right atrial pressure on the basis of inferior vena cava diameter and collapsibility as pre-
viously described [8].
Echocardiographic severity of valvular stenosis or regurgitation was assessed according to
EAE/ASE recommendations for clinical practice [9–10].
4. Dual-energy X-ray absorptiometry (DXA)
Body compositions were measured by a standardized method, using DXA and assessed using
whole body composition software (BHR-140-P Discovery A, Hologic Inc., Bedford, MA,
USA). All scans were acquired and analyzed according to each manufacturer’s standard scan-
ning and positioning protocols. DXA scanned the weight (g) of total mass, fat mass, lean body
mass, and the percentage of fat (fat mass divided by total mass) was calculated. Bone mineral
content was expressed in g, and bone mineral density (BMD) in g/cm2. The coefficient of vari-
ation for both spine and whole body calibration phantoms was less than 1%.
Statistical analysis
Continuous variables are represented as mean (± standard deviation) or median (inter-quartile
range) if non-normally distributed. Categorical variables are presented as counts and propor-
tions. Comparisons between before and after MV surgery were performed with paired t-test or
Wilcoxon signed rank test for paired continuous data. Man-Whitney U test was used for non-
parametric comparisons of continuous data between groups. Correlations of pre-operative
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SNAQ and ΔSNAQ with other variables were performed using Pearson’s coefficient (r) or
Spearman correlation. The significance level was set at p<0.05. Statistical analyses were per-
formed using SPSS version 23.0 (IBM, Armonk, NY, USA).
Results
The mean age of the study population was 52 ± 13 years, and 24 (50%) patients were male.
Mean EUROSCORE II was 1.52 ± 1.46%. The reasons for MV surgery were mitral regurgi-
tation (MR) in 32 (67%) patients and mitral stenosis (MS) in 16 (33%) patients.
In patients with MR, MV repair was performed in 26 (81%) and prosthetic MV replacement
in 6 (19%) patients. All the patients with MS underwent MV replacement.
We classified the patients according to the primary MV lesions (MR vs MS) and Table 1
shows the changes in anthropometric, echocardiographic, laboratory measurements and body
composition before and after MV surgery.
Despite no difference in BMI before and after MV surgery, pre-operative SNAQ for assess-
ment of appetite was significantly increased after surgery. Patients with pre-operative SNAQ
score <14, who were at a significant risk of weight loss >5% within 6 months, showed signifi-
cant improvement in SNAQ score after surgery (11.1 ± 1.2 vs. 13.6 ± 1.6, p<0.001) (Fig 1).
On echocardiography, LV stroke volume was significantly increased and both LAVI and
estimated RVSP (eRVSP) were significantly decreased after surgery. Low pre-operative hemo-
globin and albumin levels were significantly increased and pre-operative NT-proBNP level
was markedly decreased after MV surgery in both patients with MR and MS (Table 1).
On DXA for assessment of body composition, both pre-operative BMD and body fat per-
centage were significantly increased and pre-operative lean body mass was decreased after MV
surgery in patients with MR and no changes were observed in patients with MS.
On correlation analysis of SNAQ with anthropometric, echocardiographic, laboratory data,
and DXA profiles, only pre-operative eRVSP and ΔeRVSP values in patients with MR showed
significant correlations with the respective values of SNAQ (Table 2).
When the patients were divided into subgroups according to the changes in body fat per-
centage (median value of Δfat = 2%, Table 3), majority of the anthropometric, echocardio-
graphic, and laboratory data of both patients with MR and MS showed similar improvement
after MV surgery. However, only in patients with MR, patients with Δfat2% showed a signif-
icant difference in ΔeRVSP after surgery compared with patients with Δfat<2%. However,
patients with MS showed no significant changes in the parameters between the patients with
Δfat2% or < 2%.
While analyzing the relation with ΔeRVSP, both ΔSNAQ and Δfat% had an inverse correla-
tion with ΔeRVSP (p = 0.004 and p = 0.03, respectively) (Fig 2).
Discussion
The present study demonstrated that patients with severe MV disease showed an improvement
in their appetite, laboratory data as well as hemodynamic parameters after MV surgery.
In respect to body composition, although body weight did not change after surgery, signifi-
cant increase in body fat percentage and BMD were observed in patients with MR. Addition-
ally, the changes in SNAQ and body fat percentage showed close relations with the magnitude
of change in eRVSP in those patients with MR. These findings suggest that corrective MV sur-
gery brings favorable outcome in wasting process as well as hemodynamic improvement, and
that RV pressure overload is significantly associated with the changes in appetite and body
composition, especially in patients with severe MR.
Body composition change after mitral valve surgery
PLOS ONE | https://doi.org/10.1371/journal.pone.0203798 September 21, 2018 4 / 12
Body alterations after MV surgery
The alteration of body composition in wasting process consists of a reduction in fat mass, fat-
free mass and bone mass [4–5]. Palmieri V. et al. suggested that more severe valvular insuffi-
ciency is associated with lower body mass index (BMI) and lower body fat mass, measured
with bioimpedance [11]. Studies in dogs with mitral stenosis showed that cachectic changes
became more pronounced and they lose fat and lean body mass over time [12].
For the reversibility of wasting process, patients with heart failure who underwent heart
transplantation, showed an improved cardiac function leading to the cessation of wasting pro-
cess with subsequent weight gain[13]. However, weight gain following the transplantation is
also associated with the use of steroid and immune suppressants that cause increase in fat mass
[14].
Table 1. Changes in anthropometric, echocardiographic, laboratory measurements and body composition before and after mitral valvular surgery according to the
primary valve lesion.
Variable Before surgery 1 year after surgery
All MR MS All MR MS
(n = 48) (n = 32) (n = 16) (n = 48) (n = 32) (n = 16)
Sytolic BP, mmHg 115 ± 12 115 ± 11 111 ± 12 123 ± 14 124 ± 13 121 ± 15
Diastolic BP, mmHg 71 ± 10 71 ± 10 71 ± 11 78 ± 11 77 ± 12 82 ± 10
Heart rate, bpm 72 ± 10 72 ± 11 72 ± 10 76 ± 9 77 ± 8 75 ± 11
Body weight, kg 62 ± 12 64 ± 13 54 ± 9† 62 ± 13 65 ± 13 56 ± 9
Height, cm 164 ±9 165 ± 11 159 ± 9† 164 ±9 166 ± 10 160 ± 8
BMI, kg/m2 22.6 ± 3.1 23.3 ± 3.1 21.5 ± 2.3† 22.8 ± 3.2 23.6 ± 3.4 21.4 ± 2.2
SNAQ score 13.5 ± 2.1 13.7 ± 2.0 12.8 ± 2.4 15.1 ± 1.8 15.4 ± 1.6 14.4 ± 1.9
LVEF, % 64 ± 9 68 ± 5 58 ± 11‡ 63 ± 7 63 ± 8 62 ± 5
Stroke volume, ml 56.1 ± 14.4 60 ± 12 48 ± 12† 67.3 ± 12.4 69 ± 11 60 ± 10
LA volume index, ml/m2 78.3 ± 51.3 66 ± 41 102 ± 62† 45.4 ± 30.3 41 ± 29 53 ± 28
eRVSP,mmHg 38± 14 37 ± 14 39 ± 10 26± 5 25 ± 5 26 ± 5
Hemoglobin, g/dL 10.8 ± 2.1 10.4 ± 1.7 11.6 ± 2.6 13.5 ± 2.1 13.3 ± 2.3 13.8 ± 1.6
Albumin, g/dL 2.8 ± 0.6 2.9 ± 0.5 2.6 ± 0.6 4.4 ± 0.2 4.4 ± 0.2 4.4 ± 0.1
Creatinine, mg/dL 0.82 ± 0.18 0.84 ± 0.23 0.82 ± 0.18 0.84 ± 0.19 0.86 ± 0.21 0.80 ± 0.15
Glucose, mg/dL 86 ± 14 86 ± 12 85 ± 16 88 ± 14 85 ± 15 92 ± 11
Total cholesterol, mg/dL 177 ± 32 178 ± 36 170 ± 31 183 ± 34 183 ± 35 184 ± 31
NT-proBNP, pg/mL 288 (84–1105) 133(74–343) 1239(1015–2278)‡ 144 (68–292) 113 (67–255) 232(109–644)
Insulin, mIU/L 8.15 ± 6.47 9.21 ± 7.03 5.71 ± 3.90† 9.13 ± 7.81 8.95 ± 7.87 9.32 ± 7.71
C-peptide, ng/mL 1.68 ± 0.96 1.71 ± 1.04 1.61 ± 0.71 1.62 ± 1.04 1.55 ± 1.03 1.74 ± 1.05
HOMA-IR 1.77 ± 1.56 1.98 ± 1.69 1.26 ± 1.00† 2.08 ± 1.94 2.01 ± 1.96 2.17 ± 1.90
BMD, g/cm2 1.06 ± 0.13 1.08 ± 0.13 1.04 ± 0.15 1.09 ± 0.12 1.10 ± 0.13 1.08 ± 0.11
Lean body mass, kg 42.5 ± 10.3 45.4 ± 10.1 36.8 ± 8.3‡ 41.5 ± 9.1 43.5 ± 8.9 37.0 ± 8.1
Body fat, % 26.5 ± 7.6 25.4 ± 7.3 28.9 ± 7.9 28.3 ± 7.4 27.3 ± 7.2 30.5 ± 7.5
Values are presented as the mean ± SD or number (%) or median (IQR).
† p <0.05 vs. MR
‡ p< 0.01 vs. MR
 p <0.05 vs. before surgery
 p< 0.01 vs. before surgery.
Paired t-test or Wilcoxon signed rank test (non-parametric). BP, blood pressure;BMI, body mass index; SNAQ, simplified nutritional assessment questionnaire; LVEF,
left ventricular ejection fraction;LA, left atrial; eRVSP, estimated right ventricular systolic pressure; NT-proBNP, N-terminal pro-brain natriuretic peptide; HOMA-IR,
homeostasis model assessment for insulin resistance; BMD, bone mineral density.
https://doi.org/10.1371/journal.pone.0203798.t001
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To our knowledge, this is the first study to demonstrate the reversibility of wasting process
with the changes in body composition after corrective surgery for valvular heart disease.
Majority of our patients with severe MV disease, who were scheduled for MV surgery, showed
normal range of BMI with non-cachectic appearance preoperatively. As healthcare accessibil-
ity and HF management including cardiovascular medications improve, patients with typical
cachectic appearance are hardly seen in recent practice of cardiology.
Nonetheless, our population showed evidences of significant malnourishment, as indicated
by anemia, low albumin level, as well as poor DXA profile (low body fat percentage and
BMD).
After MV surgery, the body profile alterations in our population could be contributed to a
certain extent by the significant increase in their appetite after surgery. Similarly, Buchanan N.
et al. reported that 11 patients with severe MV disease had experienced a marked increase in
appetite after MV surgery [6].Though the precise mechanism is unclear, neurohormonal
Fig 1. Changes in short nutrition assessment questionnaire (SNAQ) before and after mitral valvular surgery
(SNAQ score<14 has been reported to be a significant risk for weight loss>5% within 6 months). Paired t-test or
Wilcoxon signed rank test (non-parametric).
https://doi.org/10.1371/journal.pone.0203798.g001
Table 2. Correlation coefficients of short nutrition assessment questionnaire scores before and after mitral valve surgery according to the primary valve lesion.
Preoperative variable SNAQ before surgery ΔVariable ΔSNAQ
All MR MS All MR MS
r p-value r p-value r p-value r p-value r p-value r p-value
BMI 0.140 0.366 -0.076 0.702 0.373 0.155 ΔBMI 0.286 0.107 0.488 0.025 -0.047 0.885
LVEF 0.140 0.364 0.001 0.996 -0.003 0.991 ΔLVEF -0.142 0.376 -0.187 0.350 -0.453 0.104
Stroke volume 0.173 0.292 -0.088 0.675 0.303 0.292 ΔStroke volume 0.074 0.677 0.219 0.316 -0.304 0.364
LAVI -0.190 0.223 -0.081 0.681 -0.024 0.934 ΔLAVI 0.162 0.317 0.412 0.033 -0.199 0.513
eRVSP -0.308 0.047 -0.424 0.028 -0.050 0.860 ΔeRVSP -0.295 0.068 -0.548 0.004 0.279 0.355
Hemoglobin -0.128 0.401 -0.145 0.454 -0.112 0.680 ΔHemoglobin 0.066 0.677 0.055 0.780 -0.003 0.991
Albumin -0.137 0.369 -0.098 0.612 -0.197 0.464 ΔAlbumin -0.048 0.767 -0.053 0.792 0.151 0.606
Log NT-proBNP -0.302 0.046 -0.251 0.198 0.107 0.693 ΔLog NT-proBNP 0.140 0.616 0.363 0.068 -0.430 0.125
HOMA-IR 0.120 0.445 -0.023 0.907 0.416 0.123 ΔHOMA-IR 0.016 0.924 0.134 0.523 0.122 0.679
BMD 0.143 0.348 0.115 0.560 0.067 0.806 ΔBMD -0.067 0.676 -0.167 0.406 0.005 0.988
Body fat 0.026 0.866 -0.136 0.483 0.011 0.969 ΔBody fat 0.291 0.065 0.388 0.041 0.149 0.627
Lean body mass 0.187 0.219 0.166 0.399 0.431 0.096 ΔLean body mass 0.104 0.516 0.144 0.472 0.016 0.957
Pearsons’s coefficient or Spearman correlation. SNAQ, simplified nutritional assessment questionnaire; MR, mitral regurgitation; MS, mitral stenosis; BMI, body mass
index; LVEF, left ventricular ejection fraction; LAVI, left atrial volume index; eRVSP, estimated right ventricular systolic pressure; NT-proBNP, N-terminal pro-brain
natriuretic peptide; HOMA-IR, homeostasis model assessment for insulin resistance; BMD, bone mineral density.
https://doi.org/10.1371/journal.pone.0203798.t002
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activation involved in poor appetite in HF might be alleviated by the corrective MV surgery,
which improves the cardiac function. In laboratory findings, NT-proBNP, a surrogate of high
LV filling pressure that stimulates lipolysis in adipose tissue [15], significantly declined and
serum albumin increased after surgery. It identifies a nutritional improvement in patients
recovering from heart failure after corrective MV surgery.
Furthermore, body compositionof this population showed alteration as an increase in body
fat percentage and BMD, despite no significant difference in the BMI before and after MV sur-
gery. As wasting process progressed in HF, fat loss precedes the loss of lean body mass, and
alterations in lean body mass may be either inconclusive or decreased [16]. Melenovsky V.
Table 3. Comparisons of changes in anthropometric, echocardiographic, and laboratory data before and after mitral valvular surgery according to the primary
valve lesion with respect to the change in body fat percentage.
MR
Variable ΔFat< 2% ΔFat2% p-value
Before surgery 1 year after surgery p-value Before surgery 1 year after surgery p-value
BMI, kg/m2 23.3 ± 2.5 22.3 ± 2.99 0.022 23.3±3.7 24.3±3.5 0.009 0.001
SNAQ 14 ± 2 15 ± 2 0.023 13.5±1.9 15.6±1.4 0.005 0.212
LVEF, % 67 ± 4 63 ± 5 0.012 68±6 62±10 0.018 0.629
Stroke volume, ml 58 ± 12 67±12 0.139 61±13 71±11 0.011 1.000
LAVI, ml/m2 63±29 40±24 0.001 69±49 41±34 <0.001 0.357
eRVSP, mmHg 31 ± 8 25 ±5 0.017 41±17 26 ±5 <0.001 0.043
Hemoglobin, g/dL 10.2±1.4 13.1±2.5 0.007 10.5±1.9 13.5±2.1 0.001 0.864
Albumin, g/dL 2.9±0.5 4.3±0.2 0.001 2.8±0.5 4.5±0.3 <0.001 0.31
Total cholesterol, mg/dL 162±27 172±38 0.551 191±34 192±32 0.705 0.879
NT-proBNP, mg/dL 105 (64–207) 107 (68–211) 0.600 275 (72–374) 113 (39–311) 0.163 0.161
HOMA-IR 1.5±0.5 1.4±1.2 0.133 2.2±2.1 2.5±2.3 0.326 0.059
BMD, g/cm2 1.05±0.08 1.07±0.09 0.026 1.10±0.15 1.12±0.15 0.093 0.45
Body fat, % 26.4±6.8 25.0±6.6 0.033 24.6±7.8 29.1±7.3 <0.001 <0.001
Lean body mass, kg 44.9±9.3 43.4±8.2 0.245 45.9±10.9 43.6±9.7 0.002 0.578
MS
Variable ΔFat<2% ΔFat2% p-value
Before surgery 1 year after surgery p-value Before surgery 1 year after surgery p-value
BMI, kg/m2 22.2±2.4 20.9±2.5 0.465 21.1±2.3 21.7±2.2 0.401 0.396
SNAQ 13.3±2.3 14.8±2.1 0.14 12.7±2.4 14.1±1.9 0.073 0.843
LVEF, % 61±3 61±6 1.000 55±14 64±3 0.068 0.120
Stroke volume, ml 48±11 56±3 0.465 49±10 65±12 0.043 0.345
LAVI, ml/m2 79±24 41±10 0.028 104±46 57±27 0.018 0.568
eRVSP, mmHg 32±10 24±4 0.068 44 ±10 28 ±7 0.012 0.079
Hemoglobin, g/dL 12.8±2.1 14.8±1.7 0.075 11.2±3.0 13.2±3.0 0.035 0.948
Albumin, g/dL 2.7±0.3 4.4±0.1 0.027 2.6±0.8 4.4±0.1 0.017 0.194
Total cholesterol, mg/dL 174±23 197±15 0.042 175±31 174±37 0.484 0.053
NT-proBNP, mg/dL 1054 (573–2503) 109 (18–369) 0.028 1239 (1084–2271) 285(220–809) 0.017 0.606
HOMA-IR 1.56±1.47 2.13±2.27 0.753 1.15±0.52 1.66±0.83 0.05 0.439
BMD, g/cm2 1.11±0.09 1.13±0.09 0.115 1.06±0.13 1.05±0.12 0.400 0.070
Body fat, % 30±10 28±8.8 0.173 27±6 32±6 0.012 0.003
Lean body mass, kg 39.2±10.7 38.7±10.1 0.345 37.0±6.5 35.7±6.6 0.208 0.302
Comparisons of Δ values between the subgroups. Values are presented as the mean ± SD or median (interquartile range). Wilcoxon signed rank test for paired variables
or Man-Whitney U test for independent variables. MR, mitral regurgitation; MS, mitral stenosis; other abbreviations as shown in Table 2.
https://doi.org/10.1371/journal.pone.0203798.t003
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et al. had identified the decrease in fat mass and relative preservation of lean body mass in
cachectic patients with advanced HF by using DXA [17]. In these patients with MR, although
the depleted body fat and BMD were replenished over one year, lean body mass was signifi-
cantly decreased after surgery. Considering that lean body mass detected by DXA is heteroge-
neous and consists of cell mass and total body water distributed in intracellular and
extracellular spaces, the significant decrease of lean body mass In this study may reflect the
loss of edema (body water) rather than the loss of cell mass with an improvement of heart fail-
ure after corrective surgery.
When we dichotomized the patients according to the primary valve lesion, both groups
showed an improvement in appetite, echocardiographic and laboratory parameter in the same
manner. Notably, even patients with MS were undersized, they had higher percentage of body
fat than patients with MR, preoperatively. After surgery, only patients with MR showed a sig-
nificant increase in BMD and body fat and the patients with MS did not. It suggests that body
wasting in pre-operative patients with MS might be less advanced and surgical correction had
less impact on body composition in patients with MS. However, it should also be taken into
account low statistical power by small sample size of patients with MS.
RV impairment and body wasting
On correlation analysis, pre-operative SNAQ and ΔSNAQ were significantly associated with
the respective values of eRVSP, and these results are limited to the patients with MR. Also,
patients with Δfat2% showed higher pre-operative eRVSP and ΔeRVSP levels than the
patients with Δ fat <2% in patients with MR. This demonstrated that both ΔSNAQ and Δfat %
have inverse relationships with ΔeRVSP and that RV pressure overload is involved in the
occurrence and recovery of wasting process in severe MV disease, especially in MR. However,
these results do not apply to the patients with MS despite the similar eRVSP values with those
with MR. Among left-sided valvular heart disease, pathophysiological adaptation in MS begins
with chronic pressure overload of LA and chronic pressure and volume overload in MR. By
non-compliant LA, pulmonary venous pressure is elevated and lead to irreversible changes as
deposition of type II collagen, which passively increases pulmonary arterial pressure (PAP).
The difference in the two diseases is that PAP in MS is rapidly decreased after relief of the
Fig 2. Relationship of ΔSNAQ and body fat percentage with ΔeRVSP in patients with mitral regurgitation.
Pearson’s coefficient(r). SNAQ, short nutritional assessmentquestionnaire; eRVSP, estimated right ventricular systolic
pressure.
https://doi.org/10.1371/journal.pone.0203798.g002
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stenosis, whereas more time could be required in MR of which pulmonary hypertension is
linked to volume overload [18]. These different responses of PAP after MV surgery might be
involved in the different results of the two diseases in this study, although the precise mecha-
nism remains unclear. However, as mentioned above, we should also consider the sample size
and less advanced body wasting of patients with MS than those with MR. Further studies with
more patients with valvular heart disease and serial follow-up are needed to confirm our
results.
In this study, we found no significant relationship between the changes in LV systolic func-
tion and body composition, which is line with the previous reports that LV EF was similar in
both cachectic and non-cachectic patients [4,19].
Although there are few data about the relation between RV function and wasting process,
growing evidence suggests the importance of RV function and the associated parameters as
principal factors of wasting process in HF [17, 20–22]. It has been reported that increased right
atrial pressure and tricuspid regurgitation (TR) were significant predictors of malnutrition
and were associated with the loss of fat mass in HF [20–22]. Melenovsky V. et al. identified
that patients with RV dysfunction had lower BMI and less body fat mass than those with pre-
served RV function, whereas lean body mass was similar in both groups [17].
For the pathogenesis of wasting process, RV impairment leads to splanchnic venous con-
gestion, liver stasis, and gastrointestinal edema, and it might be associated with anorexia, pro-
tein, and fat malabsorption. The catabolic effect of inflammatory cytokines and
neurohormone might also play an important role in weight loss [23]. However, the underlying
pathogenesis beginning with RV impairment until wasting is not fully elucidated.
The reversing of wasting process with improvement of RV dysfunction has been reported
earlier, albeit small studies. Serum protein level in a patient with severe TR complicated by
severe hypoproteinemia became normalized after tricuspid valve replacement [24], and
patients with atrial septal defect (ASD) and massive TR showed a significant weight gain after
successful ASD device closure [25]. Patients with HF and severe pulmonary hypertension, who
underwent phosphodiesterase 5 inhibitor therapy, showed a significant decrease in pulmonary
arterial pressure and maintained a steady body weight when compared with controls who
experienced significant weight loss [26].
In this study, the patients with severe TR and RV dysfunction were excluded to assess the
isolated effect of severe MV disease on body composition. Nonetheless, we found that RV pres-
sure overload in itself could affect the body composition in severe MV disease and these results
support the previous studies suggesting the crucial role of RV in the wasting process of HF.
Limitation
There are several limitations in this study. First, the study population was relatively small; a
larger sample size and serial follow-up would provide more conclusive results. Although the
noninvasive estimation of RVSP using echocardiography has been validated with invasively
measured pressures in numerous studies, right heart catheterization would be the definitive
modality for assessment of right heart pressures and function. To assess isolated effect of severe
MV disease on body composition, we excluded the patients with low LV systolic function and
other cardiomyopathies who would be expected to gain greater changes to the wasting process.
Also, patients with RV dysfunction and severe TR were excluded and these results are
restricted to the patients of MV disease without overt RV dysfunction. Since the corrective sur-
gery in isolated TR and RV dysfunction cases are limited, it is hard to determine the role of RV
dysfunction on wasting process. Most of patients had taken cardiovascular medications as
statin, beta blocker and/or calcium channel blocker, which could also affect on the metabolism.
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Since it is difficult to consider all of these aspects, we exclude only patients taking medications
which directly influence on the appetite as steroid, anti-depressant, and other appetite
stimulants.
Conclusions
We demonstrated that corrective MV surgery contributed to favorable outcomes in wasting
process as well as hemodynamic improvement in patients with severe MV disease. Particularly,
patients with higher reduction in RV pressure after MV surgery showed greater improvement
in appetite and increment in body fat percentage in patients with MR. This indicates the role
of RV pressure overload on wasting process in patients with severe MV disease.
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